179 related articles for article (PubMed ID: 20961969)
1. Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and Nutrition.
Allen NE; Tsilidis KK; Key TJ; Dossus L; Kaaks R; Lund E; Bakken K; Gavrilyuk O; Overvad K; Tjønneland A; Olsen A; Fournier A; Fabre A; Clavel-Chapelon F; Chabbert-Buffet N; Sacerdote C; Krogh V; Bendinelli B; Tumino R; Panico S; Bergmann M; Schuetze M; van Duijnhoven FJ; Bueno-de-Mesquita HB; Onland-Moret NC; van Gils CH; Amiano P; Barricarte A; Chirlaque MD; Molina-Montes ME; Redondo ML; Duell EJ; Khaw KT; Wareham N; Rinaldi S; Fedirko V; Mouw T; Michaud DS; Riboli E
Am J Epidemiol; 2010 Dec; 172(12):1394-403. PubMed ID: 20961969
[TBL] [Abstract][Full Text] [Related]
2. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.
Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA
Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161
[TBL] [Abstract][Full Text] [Related]
3. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
4. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck AR; Park Y; Brinton LA
Int J Cancer; 2013 Jan; 132(2):417-26. PubMed ID: 22553145
[TBL] [Abstract][Full Text] [Related]
5. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype.
McCullough ML; Patel AV; Patel R; Rodriguez C; Feigelson HS; Bandera EV; Gansler T; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):73-9. PubMed ID: 18187388
[TBL] [Abstract][Full Text] [Related]
6. Endometrial cancer risk with menopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
Yuk JS
Int J Gynaecol Obstet; 2023 Aug; 162(2):502-513. PubMed ID: 36964935
[TBL] [Abstract][Full Text] [Related]
7. Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort.
Canchola AJ; Chang ET; Bernstein L; Largent JA; Reynolds P; Deapen D; Ursin G; Horn-Ross PL
Cancer Causes Control; 2010 Sep; 21(9):1407-16. PubMed ID: 20431936
[TBL] [Abstract][Full Text] [Related]
8. Short and long term effects of tibolone in postmenopausal women.
Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
[TBL] [Abstract][Full Text] [Related]
9. Exogenous Hormone Use and Endometrial Cancer in U.S. Black Women.
Sponholtz TR; Palmer JR; Rosenberg LA; Hatch EE; Adams-Campbell LL; Wise LA
Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):558-565. PubMed ID: 29475971
[No Abstract] [Full Text] [Related]
10. Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition.
Tsilidis KK; Allen NE; Key TJ; Dossus L; Kaaks R; Bakken K; Lund E; Fournier A; Dahm CC; Overvad K; Hansen L; Tjønneland A; Rinaldi S; Romieu I; Boutron-Ruault MC; Clavel-Chapelon F; Lukanova A; Boeing H; Schütze M; Benetou V; Palli D; Berrino F; Galasso R; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; van Duijnhoven FJ; Braem MG; Onland-Moret NC; Gram IT; Rodríguez L; Duell EJ; Sánchez MJ; Huerta JM; Ardanaz E; Amiano P; Khaw KT; Wareham N; Riboli E
Cancer Causes Control; 2011 Aug; 22(8):1075-84. PubMed ID: 21637986
[TBL] [Abstract][Full Text] [Related]
11. Tibolone and risk of gynecological hormone sensitive cancer.
Løkkegaard ECL; Mørch LS
Int J Cancer; 2018 Jun; 142(12):2435-2440. PubMed ID: 29349823
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study.
Sweetland S; Beral V; Balkwill A; Liu B; Benson VS; Canonico M; Green J; Reeves GK;
J Thromb Haemost; 2012 Nov; 10(11):2277-86. PubMed ID: 22963114
[TBL] [Abstract][Full Text] [Related]
13. Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition.
Tsilidis KK; Allen NE; Key TJ; Sanjoaquin MA; Bakken K; Berrino F; Fournier A; Lund E; Overvad K; Olsen A; Tjønneland A; Byrnes G; Chajes V; Rinaldi S; Boutron-Ruault MC; Clavel-Chapelon F; Chang-Claude J; Kaaks R; Bergmann M; Boeing H; Koumantaki Y; Palli D; Pala V; Panico S; Tumino R; Vineis P; Bas Bueno-de-Mesquita H; van Duijnhoven FJ; van Gils CH; Peeters PH; Rodríguez L; González CA; Sánchez MJ; Chirlaque MD; Barricarte A; Dorronsoro M; Khaw KT; Rodwell SA; Norat T; Romaguera D; Riboli E
Int J Cancer; 2011 Apr; 128(8):1881-9. PubMed ID: 20533550
[TBL] [Abstract][Full Text] [Related]
14. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.
Anderson GL; Judd HL; Kaunitz AM; Barad DH; Beresford SA; Pettinger M; Liu J; McNeeley SG; Lopez AM;
JAMA; 2003 Oct; 290(13):1739-48. PubMed ID: 14519708
[TBL] [Abstract][Full Text] [Related]
15. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
Beral V; Bull D; Reeves G;
Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
[TBL] [Abstract][Full Text] [Related]
16. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
[TBL] [Abstract][Full Text] [Related]
17. Tibolone and risk of endometrial polyps: a prospective, comparative study with hormone therapy.
Perez-Medina T; Bajo-Arenas J; Haya J; Sanfrutos L; Iniesta S; Bueno B; Castelo-Branco C
Menopause; 2003; 10(6):534-7. PubMed ID: 14627862
[TBL] [Abstract][Full Text] [Related]
18. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.
Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR
Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897
[TBL] [Abstract][Full Text] [Related]
19. [Hormone therapy effect in postmenopausal women with history of endometrial cancer].
Arteaga-Gómez AC; Castellanos-Barroso G; Colin-Valenzuela A; García-Vargas J; Márquez-Acosta G; Reyes-Muñoz E
Ginecol Obstet Mex; 2011 Jan; 79(1):11-7. PubMed ID: 21966778
[TBL] [Abstract][Full Text] [Related]
20. Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition.
Friedenreich C; Cust A; Lahmann PH; Steindorf K; Boutron-Ruault MC; Clavel-Chapelon F; Mesrine S; Linseisen J; Rohrmann S; Boeing H; Pischon T; Tjønneland A; Halkjaer J; Overvad K; Mendez M; Redondo ML; Garcia CM; Larrañaga N; Tormo MJ; Gurrea AB; Bingham S; Khaw KT; Allen N; Key T; Trichopoulou A; Vasilopoulou E; Trichopoulos D; Pala V; Palli D; Tumino R; Mattiello A; Vineis P; Bueno-de-Mesquita HB; Peeters PH; Berglund G; Manjer J; Lundin E; Lukanova A; Slimani N; Jenab M; Kaaks R; Riboli E
Cancer Causes Control; 2007 May; 18(4):399-413. PubMed ID: 17297555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
